In a small sample of 57 retrovirus integration sites (RISs) isolated from 23 end-stage lymphomas induced in NMRI mice by the Blymphotropic Akv wt or an enhancer mutant hereof, Akv1-99, we identified 14 novel RISs and defined 9 novel CISs (common insertion sites). Moreover, when comparing with RISs from tumors induced by the T-lymphomagenic SL3-3, we observed that SL3-3 targets RefSeq promoter regions with a significantly higher frequency than Akv/Akv1-99 and in an orientation-dependent way. Altogether, our results strongly emphasize the importance of host genetic background and virus type for retroviral insertion mutagenesis screens and suggest that different types of MLV may favor specific genomic regions and orientations in order exert optimal effect on target gene expression during lymphoma induction and development.
Introduction
Tumor induction by the non-acute-transforming retroviruses is a multistep process in which insertional mutagenesis plays a fundamental role and where the effect of the individual integrated provirus will depend on the particular location of the insertion site relative to the targeted gene. The integrated provirus may affect the neighboring genes in a variety of ways by what have been described as promoter insertion, enhancer insertion, and/or truncation of a normal cellular gene (Rosenberg and Jolicoeur, 1997; Uren et al., 2005) .
In the era of post-genome-sequence completion, retroviral insertional mutagenesis in mice has proven its significance as a potent instrument to identify candidate cancer genes, in particular, those related to diseases in the hematopoietic system (Erkeland et al., 2004; Hansen et al., 2000; Joosten et al., 2002; Kim et al., 2003; Li et al., 1999; Mikkers et al., 2002; Sorensen et al., 1996) . Several independent screening studies have thus mapped the exact positions and orientations of hundreds of proviral insertions, and much of the published collection of miscellaneous retrovirus integration sites (RISs) has been organized in the Retroviral Tagged Cancer Gene Database (RTCGD; http://RTCGD.ncifcrf.gov; Akagi et al., 2004) . For the present, this database (version mm6) contains more than 2200 insertions, which define more than 350 common integration sites (CISs).
Evidently, the strength of combining RISs from many different sources lies in the opportunity of discovering novel rare CISs and improving the resolution of already known CISs. However, this also precludes detailed and faithful comparison studies between different model systems since several parameters will differ between the various studies; parameters of which the most influencing ones would be different host genetic backgrounds, different virus strains, and different PCR-based strategies for tag identification. As an example, we have in a previous study examined the integration site pattern around the Fos/Jdp2/Batf locus in tumors induced by SL3-3 or Akv murine leukemia viruses (MLVs) in NMRI or SWR genetic background (Rasmussen et al., 2005) , and we noted a clear difference from the pattern within the same locus observed by Hwang et al. (2002) , whose studies were based upon Moloney MLV-induced tumors in p27+/+ or p27−/− C57/B6J×129/Sv hybrid mice. Due to usage of different mouse strains, different viruses, and different PCRbased methods, it was not possible to determine whether host genetic composition and/or inherent viral features were the main contributor to the observed differences. To clarify such issues, equivalent experimental setups are needed.
Here, we report on the analysis of provirus integration sites from three comparable studies, where the mouse strain and the PCR method for tag identification are unchanged. We observe that in end-stage lymphomas the T-lymphomagenic SL3-3 MLV is found much more frequently in promoter regions than the Blymphomagenic Akv and Akv1-99 MLVs. Likewise, we see a significant lack of Akv1-99 insertions downstream of the target gene compared to Akv wt. Due to the comparable experimental setups, the observed differences in integration site pattern in end-stage tumors can be associated with virus characteristics rather than mouse genetic background or PCR strategy. Moreover, by using this particular combination of mouse strain, virus types, and PCR method, we identify 14 novel RISs and define 9 novel CISs.
Results and discussion
Integration site analyses of Akv-and Akv1-99-induced tumors Akv1-99 is an ecotropic MLV derived from Akv MLV by deletion of one copy of the 2 × 99-bp transcriptional enhancer in the proviral LTR (Fig. 1) . Both viruses induce B-cell lymphomas with nearly 100% incidence in randomly bred NMRI mice and with a mean latency period of about 12 months (Lovmand et al., 1998) . By a simple two-step PCR method, which has previously been described as an efficient technique for the isolation and sequencing of provirus-host junctions (MartinHernandez et al., 2001; Sorensen et al.,1993 Sorensen et al., , 1996 , we have from 23 Akv-wt-and Akv1-99-induced tumors from an earlier study (Lovmand et al., 1998 ) amplified a total of 57 proviral flanking sequences, representing 28 tags from 10 Akv-wtinduced tumors and 29 tags from 13 Akv1-99-induced tumors. Of these, 24 and 26 tags, respectively, could be located within ±100 kb of a RefSeq (Maglott et al., 2000; Pruitt and Maglott, 2001) (Fig. 2, upper panel) . Since the RTCG database already contains about 2300 RISs, it was not foreseen that we from such a small sample were able to identify 14 novel RISs (Table 1) and furthermore define 9 novel CISs (Table 1) . Some of the identified RISs may be "passenger integrations" that by chance have been drawn into end-stage tumor cells, but play no role in the oncogenic process (a feature that may as well apply to RISs already included in the RTCGD). However, since CISs define regions or genes that are targeted by two or more viruses in independent experiments, these regions most likely are of biological relevance and do contribute to induction or progression of tumor development. Thus, altogether our findings strongly emphasize the importance of the experimental model system.
As previously published, the N-ras/unr locus defines a CIS within the Akv1-99 setting (Martin-Hernandez et al., 2001) since two tags target this chromosomal region, and, in addition, we have defined the Pvt-1 locus (downstream of c-myc, a position classified as c-myc RIS within the RTCGD) as a CIS within the Akv wt setting since two tags out of 28 could be addressed to this locus (see Table 1 ).
Distinct regions of the target gene are hit by Akv wt, Akv1-99, and SL3-3
The collection of Akv wt and Akv1-99 sequence tags isolated from comparable experimental settings allowed us to evaluate if a general difference in integration site position relative to the targeted gene could be detected. Besides, we were able to include in this analysis sequence tags isolated from SL3-3-induced tumors from one of our early studies (Sorensen et al., 1996) since those tumors were induced in the same host genetic background (randomly bred NMRI mice) and the tags were isolated by means of the exact same PCR method. In contrast to Akv (and Akv1-99), SL3-3 induces primarily T-cell lymphomas with an average latency period of about 3 months in ran- domly bred NMRI mice (Hallberg et al., 1991) , and as previously reported (Sorensen et al., 1996) , 38 tag sequences (Table 1) were isolated from 20 tumors, and, of these, 32 tag sequences could be located within ±100 kb of a RefSeq (Fig. 2, upper panel) .
From the defined chromosomal position (UCSC Genome Browser; mm6), we assigned each proviral insertion to either upstream of (−100 to −2 kb; distance to RefSeq), promoter (−2000 to +1; positions relative to transcription start site (+1)), within or downstream of (<100 kb; distance to RefSeq) the relevant RefSeq. Table 2 and Fig. 2 show the proportion of the tags positioned within each of these four regions. For the upstream region (2 < 100 kb), no clear difference between the three viruses could be detected. The orientations of the inserted proviruses in this region are more or less equally distributed with approximately half of the proviruses located in the same (+) and half of the proviruses located in opposite (−) transcriptional orientation compared to that of the target gene, regardless of injected virus. It thus appears that there is no need for a specific orientation in this region, no matter the virus type, possibly reflecting that transcriptional interference is not a problem when the two promoters (provirus and target gene) are located far apart.
Conversely, a remarkable difference can be observed within the promoter region between the three viruses. Thus, more than one fourth (9/32) of all SL3-3 integrations are located here, and what is more, 7 of these (∼21.9%) are in (−) orientation (Fig. 2 and Table 2 ). This is in sharp contrast to the Akv and Akv1-99 insertions of which 0 of 24 and 1 of 26, respectively, could be detected in (−) orientation within this area. This striking difference probably reflects an inherent constraint on individual viral promoter/enhancer structures that makes them dependent on optimal genomic positions and orientations to exert their effect on target gene expression in the relevant cell type. In this case, it suggests that insertion in (−) orientation into the promoter region of the target gene by "enhancer activation" would be a favorable mode of target gene regulation in SL3-3-induced T-cell lymphomagenesis in NMRI mice. In contrast, both Akv insertions and one of two Akv1-99 insertions are in (+) orientation, suggesting the promoter/enhancer potential of the Akv type viruses to go well with a "promoter activation" of the target gene in MLV-induced B-cell lymphomagenesis in NMRI mice, an implication of which adjusts to our previous observation for the Akv1-99 activation of N-ras gene (MartinHernandez et al., 2001) . It should be pointed out that 2 of the 7 (−) SL3-3 insertions are within the c-myc locus, which might bias the comparison analyses. However, even if just one c-myc insertion is included, the difference would still be statistically significant, at least for Akv wt versus SL3-3 (0/24 compared to 6/31 would result in a two-tailed p value of 0.0300).
The distribution of insertions within the target RefSeq (Fig.  2) does not reveal differences of statistical significance among the three viruses. Yet, it might be worth to note that far the majority of the Akv1-99 insertions (18/26, 69.2%) are located here, while both Akv wt and SL3-3 insertions tend to be more evenly dispersed over the four defined regions (Fig. 2) . This apparent Akv1-99 clustering within the target gene is further supported by the clear difference between Akv wt (7/24) and Akv1-99 (1/26) insertions in the region downstream of the target RefSeq (Fig. 2 and Table 2 ). 
a Seq ID refers to tumor no.-seq no.; i.e. 2-5 refers to tumor no. 2-seq. no. 5 within the series in question (e.g. Akv wt). b The gene (or RefSeq) closest to the integrated provirus is given (UCSC, mouse mm6 assembly). + or − indicates the transcriptional orientation of the integrated provirus relative to that of the gene/RefSeq. c For each Akv wt and Akv1-99 insertion, it is indicated, based on RTCGD (mm6), whether a novel RIS has been defined. -signifies that the gene/RefSeq is already defined as a RIS/CIS in the database. n.a.; not applicable, refers to the fact that all SL3-3 insertions have already been included in RTCGD.
d For each Akv wt and Akv1-99 insertion, it is indicated, based on RTCGD (mm6), whether a novel CIS has been defined. The definition follows the recommendations from RTCGD with a window size of 100 kb, 50 kb, and 30 kb for CISs with 4 (or more), 3, or 2 insertions, respectively. * indicates an exception from this rule since the two integration sites -separated by about 175 kb -were found within introns of the same gene, Tcf4. 
Lack of correlation between Akv enhancer repeat numbers and insertion within RefSeq
The tendency of Akv1-99 proviruses to cluster inside the target gene may reflect that loss of one enhancer repeat would influence the "favorable regions of insertions" with respect to the provirus strength required to affect target gene expression during the lymphomagenic process. In order to pursue this, we analyzed the proviral enhancer structure of the individual integrations in the Akv wt tumors. The 5′LTR enhancer was PCR-amplified by a genomic primer (constructed in each case from the specific integration site sequence; FP, Fig. 1 ) together with a proviral-specific primer located in U3 downstream of the enhancer region (VP, Fig. 1 ). Altogether, we amplified 14 integration sites, and in 6 of these, it turned out that exactly one repeat had been lost (no other mutations were identified), while in the remaining 8 cases the input 2 × 99 bp repeat was retained (Table 3) . However, irrespective of the number of enhancer repeats recovered in the lymphoma tissues, half of the insertions (3 out of 6 and 4 out of 8; Table 3 ) were located within the RefSeq. Thus, the above notion about a possible correlation between number of enhancer repeats and tendency to cluster within the target gene could not be supported by this kind of analysis. The enhancer repeat structures of the Akv1-99 insertions were analyzed as well in 15 cases of which none revealed any mutations (Table 3) .
Conclusions
Several studies have focused on defining novel RISs and CISs in MLV-induced cancers in mice (Erkeland et al., 2004; Hansen et al., 2000; Johansson et al., 2004; Kim et al., 2003; Li et al., 1999; Lund et al., 2002; Mikkers et al., 2002; Suzuki et al., 2002) , where the majority of the identified integration sites are selected for during the tumorigenic process. Other studies have dealt with the related theme of retroviral DNA integration mechanisms and site preferences, where unselected integration sites have been the subject of analyses. In the latter case, it has been shown that avian sarcoma-leukosis virus (ASLV), human immunodeficiency virus (HIV), and MLV show distinct target site preferences, with MLV showing an inclination to integrate near transcription start sites (Hematti et al., 2004; Mitchell et al., 2004; Wu et al., 2003) . It should be noted, though, that MLV insertions in these cases are represented by infecting HeLa cells with pseudotyped Moloney MLVs.
In the present study, we have shown that, although MLVs may reveal a general preference for specific insertion areas in the process of integration, the picture might look quite different after selection during a tumorigenic process. Different types of MLV may in certain cell type contexts favor distinct genomic regions and orientations to perform in an optimal way. Moreover, we have exposed clearly the importance of the experimental model system (mouse strain and virus type) with respect to the resulting RISs and CISs that are identified as putative cancerrelated genes in retroviral insertional mutagenesis studies in mice.
Materials and methods

Origin of lymphomas and MLV types
Tumors originate from previous studies: Akv and Akv1-99-induced tumors in randomly bred NMRI mice (Lovmand et al., 1998 ) and SL3-3-induced tumors in randomly bred NMRI mice (Hallberg et al., 1991; Sorensen et al., 1996) .
Provirus integration site isolation
Genomic DNA was extracted from frozen tissues, and provirus integration sites were amplified by a two-step PCR method described previously (Sorensen et al., 1996; Sorensen et al., 1993) . The resulting PCR products were purified, and sequences were determined by the use of ABI 7300 Biosystems.
Provirus integration site analysis
The sequence of each provirus integration site was compared (BLAT search) to the UCSC Genome Browser, version mm6, and in most cases the tag sequence displayed unambiguous chromosomal position (see Fig. 2 ). Furthermore, to identify possible novel provirus integration sites, the individual integration sites were concomitantly matched up to the Retroviral Tagged Cancer Gene Database (RTCGD; http://RTCGD.ncifcrf. gov; Akagi et al., 2004) .
From the exact chromosomal position, each integration site was -when possible -placed relative to a target gene/RefSeq; either upstream of (−100 to −2 kb), within the promoter (defined here as the 2 kb immediately upstream of the transcription start site), within (within the boundaries of the RefSeq), or downstream of (less than a distance of 100 kb) the target Ref-Seq. Fig. 2 and Table 2 . a Enhancer repeat structures in end-stage tumors. b "Outside" is more than 100 kb apart from the closest RefSeq (both up-and downstream).
